ISOTECHNIKA RECEIVES U.S. PATENT FOR LEAD IMMUNOSUPPRESSIVE DRUG

Isotechnika has been issued U.S. Patent No. 7,060,672 for its lead immunosuppressive drug, ISA247.

The patent, entitled "Novel Cyclosporin Analog Formulations," is the first patent to be issued in this patent family in the U.S. These patent claims have been filed in a total of 36 countries.